Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 01-1997 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,569 | 2,831 | 1,560 | 629 | 371 |
| Income taxes - deferred | -98 | -138 | 195 | -70 | N/A |
| Accounts receivable | -544 | -3,936 | 1,365 | N/A | N/A |
| Other Working Capital | 1,933 | -1,243 | -2,535 | N/A | N/A |
| Other Operating Activity | 2,727 | 7,043 | -650 | 4,962 | 8,903 |
| Operating Cash Flow | $6,587 | $4,557 | $-65 | $5,521 | $9,274 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -985 | -6,076 | -5,459 | -7,198 | -3,932 |
| Other Investing Activity | 111 | -483 | 3,964 | 559 | 594 |
| Investing Cash Flow | $-874 | $-6,559 | $-1,495 | $-6,639 | $-3,339 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 69 | 1,690 | 1,747 | 148 |
| Dividend Paid | -2,119 | -2,762 | -650 | -1,468 | -4,526 |
| Other Financing Activity | -399 | 3,452 | 130 | 4,472 | -148 |
| Financing Cash Flow | $-2,517 | $759 | $1,170 | $4,752 | $-4,526 |
| Beginning Cash Position | 102 | 1,312 | 390 | -3,215 | -4,748 |
| End Cash Position | 3,298 | 138 | 65 | 419 | -3,413 |
| Net Cash Flow | $3,196 | $-1,243 | $-390 | $3,634 | $1,410 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,587 | 4,557 | -65 | 5,521 | 9,274 |
| Capital Expenditure | -985 | -6,145 | -5,654 | -7,268 | -3,932 |
| Free Cash Flow | 5,602 | -1,588 | -5,719 | -1,747 | 5,342 |